The drug works by inhibiting replication of the hepatitis C virus; researchers noted that both hepatitis C and Zika belong to the same viral family and bore strong structural similarities that could
make sofosbuvir effective against the latter.
Not exact matches
Sofosbuvir,
made by Gilead Sciences in Foster City, California, debuted last December at $ 1,000 a pill — $ 84,000 for a 12 - week course.